Asbestos-Related Diseases

New England Journal of Medicine

Volumn 320, Issue 26, 1989, Pages 1721-1730

  Mossman, Brooke T ^a,b   Gee, J Bernard L ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ASBESTOSIS; DIGESTIVE SYSTEM CANCER; HUMAN; LARYNX CANCER; LUNG CANCER; MESOTHELIOMA; PRIORITY JOURNAL; REVIEW;

EID: 0024393713     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198906293202604     Document Type: Review

References (103)

1. McDonald JC. Health implications of environmental exposure to asbestos. Environ Health Perspect 1985; 62: 319–28.
2. National Research Council, Committee on Nonoccupational Health Risks of Asbestiform Fibers. Asbestiform fibers: nonoccupational health risks. Washington, D.C.: National Academy Press, 1984.
3. Churg A, Wamock ML. Asbestos fibers in the general population. Am Rev Respir Dis 1980; 122: 669–78.
4. Haque AK, Kanz MF. Asbestos bodies in children's lungs: an association with sudden infant death syndrome and bronchopulmonary dysplasia. Arch Pathol Lab Med 1988; 112: 514–8.
5. Com M. Perspective on the potential risk and management options for asbestos in buildings. Presented at the 22nd International Congress on Occupational Health, 1989.
6. Mineral resources of the Union of South Africa. 4th ed. Pretoria, South Africa: Government Printer, 1959:357–67.
7. Harington IS. Occurrence of oils containing 3:4-benzpyrene and related substances in asbestos. Nature 1962; 193: 43–5.
8. Background information on substitutes for asbestos. Washington, D.C.: Environmental Protection Agency, Office of Toxic Substances, 1980.
9. Woodworth CD, Mossman BT, Craighead JE. Interaction of asbestos with metaplastic squamous epithelium developing in organ cultures of hamster trachea. Environ Health Perspect 1983; 51: 27–33.
10. Pooley FD. Asbestos mineralogy. In: Amman K, Aisner J, eds. asbestos-related malignancy. Orlando, Fia.: Grune & Stratton, 1987:3–27.
11. Timbrell V, Bevan NE, Davies AS, Munday DE. Hollow casts of lungs for experimental purposes. Nature 1970; 225: 97–8.
12. Roggli VL, Brody AR. Changes in numbers and dimensions of chrysotile asbestos fibers in lungs of rats following short-term exposure. Exp Lung Res 1984; 7: 133–47.
13. Jaurand MC, Bignon J, Sebastien P, Goni J. Leaching of chrysotile asbestos in human lungs: correlation with in vitro studies using rabbit alveolar macrophages. Environ Res 1977; 14: 245–54.
14. Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff IJ. Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death. Br J Ind Med 1988; 45: 182–7.
15. Jones JSP, Smith PG, Pooley FD. The consequences of exposure to asbestos dust in a wartime gas-mask factory. In: Wagner JC, ed. Biological effects of mineral fibres. Vol. 2. Lyon, France: International Agency for Research on Cancer, 1980:137–53. (IARC scientific publications no. 30.)
16. Jones JSP, Roberts GH, Pooley FD. The pathology and mineral content of lungs in cases of mesothelioma in the United Kingdom in 1976. In: Wagner JC, ed. Biological effects of mineral fibres. Vol. 2. Lyon, France: International Agency for Research on Cancer, 1980:187–99. (IARC scientific publications no. 30.)
17. Peto J, Doll R, Hermon C, Binns W, Clayton R, Goffe T. Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg 1985; 29: 305–55.
18. Armstrong BK, de Klerk NH, Musk AW, Hobbs MS. Mortality in miners and millers of crocidolite in Western Australia. Br J Ind Med 1988; 45: 5–13.
19. Enterline PE, Henderson VL. Geographic patterns for pleural mesothelioma deaths in the United States, 1968–81. JNCI 1987; 79: 31–7.
20. Connelly RR, Spirtas R, Myers MH, Percy CL, Fraumeni JF Jr. Demographic patterns for mesothelioma in the United States. JNCI 1987; 78: 1053–60.
21. Hughes JM, Weill H. Asbestos exposure — quantitative assessment of risk. Am Rev Respir Dis 1986; 133: 5–13.
22. Antman KH, Corson JM. Benign and malignant pleural mesothelioma. Clin Chest Med 1985; 6: 127–40.
23. Grant DC, Seltzer SE, Antman KH, Finberg HJ, Koster K. Computed tomography of malignant pleural mesothelioma. J Comput Assist Tomogr 1983; 7: 626–32.
24. Craighead JE. Current pathogenetic concepts of diffuse malignant mesothelioma. Hum Pathol 1987; 18: 544–57.
25. Warhol MJ. Electron microscopy in the diagnosis of mesothelioma with routine biopsy, needle biopsy and fluid cytology. In: Antman K, Aisner J, eds. Asbestos-related malignancy. Orlando, Fia.: Grane & Stratton, 1987:201–24.
26. Bignon J, Sebastien P, Di Menza L, Payan H. French mesothelioma register. Ann NY Acad Sci 1979; 330: 455–66.
27. Peto J, Seidman H, Selikoff IJ. Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer 1982; 45: 124–35.
28. Seidman H, Selikoff IJ, Gelb SK. Mortality experience of amosite asbestos factory workers: dose–response relationships 5 to 40 years after onset of short-term work exposure. Am J Ind Med 1986; 10: 479–514.
29. Pott F, Friedrichs KH. Tumoren der Ratte nach i. p.-Injektion faserför-miger Stäube. Naturwissenschaften 1972; 59: 318.
30. Stanton MF, Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. JNCI 1972; 48: 797–821.
31. McDonald JC, McDonald AD. Epidemiology of asbestos-related lung cancer. In: Antman K, Aisner J, eds. Asbestos-related malignancy. Orlando, Fia.: Grane & Stratton, 1987:57–79.
32. Saracci R. Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction. Int J Cancer 1977; 20: 323–31.
33. Saracci The interactions of tobacco smoking and other agents in cancer etiology. Epidemiol Rev 1987; 9: 175–93.
34. Berry G, Newhouse ML, Antonis P. Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Br J Ind Med 1985; 42: 12–8.
35. Churg AM, Wamock ML. Numbers of asbestos bodies in urban patients with lung cancer and gastrointestinal cancer and matched controls. Chest 1979; 76: 143–9.
36. Harber P, Mohsenifar Z, Oren A, Lew M. Pleural plaques and asbestosassociated malignancy. J Occup Med 1987; 29: 641–4.
37. Bateman ED, Benatar SR. Asbestos-induced diseases: clinical perspectives. Q J Med 1987; 62: 183–94.
38. Berry G, Newhouse ML. Mortality of workers manufacturing friction materials using asbestos. Br J Ind Med 1983; 40: 1–7.
39. Gardner MJ, Winter PD, Pannett B, Powell CA. Follow up study of workers manufacturing chrysotile asbestos cement products. Br J Ind Med 1986; 43: 726–32.
40. Ohlson CG, Hogstedt C. Lung cancer among asbestos cement workers: a Swedish cohort study and a review. Br J Ind Med 1985; 42: 397–402.
41. Thomas HF, Benjamin IT, Elwood PC, Sweetnam PM. Further follow-up of workers from an asbestos cement factory. Br J Ind Med 1982; 39: 273–6.
42. Churg A. Lung asbestos content in long-term residents of a chrysotile mining town. Am Rev Respir Dis 1986; 134: 125–7.
43. Cordier S, Lazar P, Brochard P, Bignon J, Ameille J, Proteau J. Epidemiologic investigation of respiratory effects related to environmental exposure to asbestos inside insulated buildings. Arch Environ Health 1987; 42: 303–9.
44. Hodgson JT, Jones RD. Mortality of asbestos workers in England and Wales 1971–81. Br J Ind Med 1986; 43: 158–64.
45. Spencer H, ed. Pathology of the lung. Vol. 2. 4th ed. Oxford: Pergamon Press, 1985:885.
46. Kuschner M. The effects of MMMF on animal systems: some reflections on their pathogenesis. Ann Occup Hyg 1987; 31: 791–7.
47. Liddell FD, McDonald JC. Radiological findings as predictors of mortality in Quebec asbestos workers. Br J Ind Med 1980; 37: 257–67.
48. Parkes WR, ed. Occupational lung disorders. 2nd ed. London: Butter-worth, 1982:294.
49. Whitwell F, Newhouse ML, Bennett DR. A study of the histological cell types of lung cancer in workers suffering from asbestosis in the United Kingdom. Br J Ind Med 1974; 31: 298–303.
50. Churg A. Lung cancer cell type and asbestos exposure. JAMA 1985; 253: 2984–5.
51. Baum GL, Gitter S, Goldsmith JR, et al. Advances in asbestos disease research: common practical problems — panel discussion. Am J Ind Med 1986; 10: 563–72.
52. Browne K. Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers? Br J Ind Med 1986; 43: 145–9.
53. Kipen HM, Lilis R, Suzuki Y, Valciukas JA, Selikoff IJ. Pulmonary fibrosis in asbestos insulation workers with lung cancer: a radiological and histopathological evaluation. Br J Ind Med 1987; 44: 96–100.
54. Wamock ML, Isenberg W. Asbestos burden and the pathology of lung cancer. Chest 1986; 89: 20–6.
55. Enterline PE, Hartley J, Henderson V. Asbestos and cancer: a cohort followed up to death. Br J Ind Med 1987; 44: 396–401
56. Doll R, Peto J. Other asbestos-related neoplasms. In: Antman K, Aisner J, eds. Asbestos-related malignancy. Orlando, Fia.: Grane & Stratton, 1987:81–98.
57. Chan CK, Gee JB. Asbestos exposure and laryngeal cancer: an analysis of the epidemiologic evidence. J Occup Med 1988; 30: 23–7.
58. Selikoff IJ, Hammond EC, Churg J. Asbestos exposure, smoking, and neoplasia. JAMA 1968; 204: 106–12.
59. Edelman DA. Exposure to asbestos and the risk of gastrointestinal cancer: a reassessment. Br J Ind Med 1988; 45: 75–82.
60. American Thoracic Society. Medical Section of the American Lung Association: the diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1986; 134: 363–8.
61. Franzblau A, Lilis R. The diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1987; 136: 790–1.
62. Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Arch Pathol Lab Med 1982; 106: 544–96.
63. Gaensler EA, Jederlinic PJ, McLoud TC. Progression of asbestosis. Chest 1987; 91: 305. abstract.
64. Agostoni P, Smith DD, Schoene RB, Robertson HT, Butler J. Evaluation of breathlessness in asbestos workers: results of exercise testing. Am Rev Respir Dis 1987; 135: 812–6.
65. Weiss W. Cigarette smoke, asbestos, and small irregular opacities. Am Rev Respir Dis 1984; 130: 293–301.
66. Lilis R, Selikoff II, Lerman Y, Seidman H, Gelb SK. Asbestosis: interstitial pulmonary fibrosis and pleural fibrosis in a cohort of asbestos insulation workers: influence of cigarette smoking. Am J Ind Med 1986; 10: 459–70.
67. Begin R, Masse S, Sebastien P, et al. Asbestos exposure and retention as determinants of airway disease and asbestos alveolitis. Am Rev Respir Dis 1986; 134: 1176–81.
68. Begin R, Boileau R, Peloquin S. Asbestos exposure, cigarette smoking, and airflow limitation in long-term Canadian chrysotile miners and millers. Am J Ind Med 1987; 11: 55–66.
69. Churg A, Wright JL, Wiggs B, Pare PD, Lazar N. Small airways disease and mineral dust exposure: prevalence, structure, and function. Am Rev Respir Dis 1985; 131: 139–43.
70. Becklake MR, Ernst P. Asbestos exposure and airway responses. In: Gee JBL, ed. Occupational lung disease. New York: Churchill Livingstone, 1984:25–49.
71. Lerman Y, Selikoff IJ, Lilis R, Seidman H, Gelb SK. Clinical findings among asbestos workers in U.S.: influence of cigarette smoking. Am J Ind Med 1986; 10: 449–58.
72. Rom WN, Bitterman PB, Rennard SI, Cantin A, Crystal RG. Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis 1987; 136: 1429–34.
73. Robinson BW, Rose AH, James A, Whitaker D, Musk AW. Alveolitis of pulmonary asbestosis: bronchoalveolar lavage studies in crocidolite- and chrysotile-exposed individuals. Chest 1986; 90: 396–402.
74. Gee JBL, Lwebuga-Mukasa J. Cellular and matrix mechanisms in occupational lung disease. In: Morgan WKC, Seaton A, eds. Occupational lung diseases. 2nd ed. Philadelphia: W.B. Saunders, 1984:163–95.
75. Rennard S, Bitterman B, Ozaki T, Crystal R. Colchicine blocks the release of mediators of fibrosis by human alveolar macrophages. Clin Res 1984; 32: 246A. abstract.
76. Mikes PS, Polomski L, Gee JBL. Mepacrine but not mast cell active agents impair neutrophil migration into rat lungs. Clin Res 1987; 35: 536A. abstract.
77. Geliert AR, Macey MG, Uthayakumar S, Newland achéal, Rudd RM. Lymphocyte subpopulations in bronchoalveolar lavage fluid in asbestos workers. Am Rev Respir Dis 1985; 132: 824–8.
78. Costabel U, Bross KJ, Huck E, Guzman J, Matthys H. Lung and blood lymphocyte subsets in asbestosis and in mixed dust pneumoconiosis. Chest 1987; 91: 110–2.
79. Bignon J, Jaurand M-C. Asbestos fiber toxicity and lung disease. In: Gee JBL, ed. Occupational lung disease. New York: Churchill Livingstone, 1984:51–73.
80. Bignon J, Gee JBL. Pleural fibrogenesis. In: Lung biology in health and disease. Vol. 30. Chrétien J, Bignon J, Hirsch A, eds. The pleura in health and disease. New York: Marcel Dekker, 1985:417–43.
81. Robinson BW, Musk AW. Benign asbestos pleural effusion: diagnosis and course. Thorax 1981; 36: 896–900.
82. Rossiter CE, Bristol LJ, Cartier PH, et al. Radiographic changes in chrysotile asbestos mine and mill workers of Quebec. Arch Environ Health 1972; 24: 388–400.
83. Gibbs GW. Etiology of pleural calcification: a study of Quebec chrysotile asbestos miners and millers. Arch Environ Health 1979; 34: 76–83.
84. Stephens M, Gibbs AR, Pooley FD, Wagner JC. Asbestos induced diffuse pleural fibrosis: pathology and mineralogy. Thorax 1987; 42: 583–8.
85. McDonald AD, McDonald JC. Epidemiology of malignant mesothelioma. In: Antman K, Aisner J, eds. Asbestos-related malignancy. Orlando, Fla.: Grune & Stratton, 1987:31–56.
86. Churg A, Wiggs B. Fiber size and number in workers exposed to processed chrysotile asbestos, chrysotile miners, and the general population. Am J Ind Med 1986; 9: 143–52.
87. Wagner JC, Newhouse ML, Corrin B, Rossiter CE, Griffiths DM. Correlation between fibre content of the lung and disease in east London asbestos factory workers. Br J Ind Med 1988; 45: 305–8.
88. Sebastien P, McDonald JC, McDonald AD, Case B, Harley R. Respiratory cancer in chrysotile textile and mining industries: exposure inferences from lung analysis. Br J Ind Med 1989; 46: 180–7.
89. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960; 17: 260–71.
90. Kuschner M, Wright G. The effects of intratracheal instillation of glass fiber of varying size in guinea pigs. In: Occupational exposure to fibrous glass — proceedings of a symposium. Rockville, Md.: National Institute for Occupational Safety and Health, 1976:151–68. (HEW no. (NI0SH)76–151.)
91. David JM, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol 1986; 67: 415–30.
92. Artvinli M, Baris YI. Malignant mesotheliomas in a small village in the Anatolian region of Turkey: an epidemiologic study. JNCI 1979; 63: 17–22.
93. McConnochie K, Simonato L, Mavrides P, et al. Mesothelioma in Cyprus. In: Bignon J, Peto J, Saracci R, eds. Non-occupational exposure to mineral fibers. Lyon, France: International Agency for Research on Cancer, 1989:411–9. (IARC publication no. 90.)
94. Boutin C, Viallat JR, Steinbauer J, Dufour G, Gaudichet A. Bilateral pleural plaques in Corsica: a marker of non-occupational asbestos exposure. In: Bignon J, Peto J, Saracci R, eds. Non-occupational exposure to mineral fibres. Lyon, France: International Agency for Research on Cancer, 1989:406–10. (IARC publication no. 90.)
95. Weill H, Hughes JM. Asbestos as a public health risk: disease and policy. Annu Rev Public Health 1986; 7: 171–92.
96. Report to the U.S. Consumer Product Safety Commission by the Chronic Hazard Advisory Panel on Asbestos. Washington, D.C.: Consumer Product Safety Commission, 1983.
97. Airborne asbestos health assessment update. Washington, D.C.: Environmental Protection Agency, 1986.
98. Acheson ED, Gardner MJ. Asbestos: the control limit for asbestos. London: Her Majesty's Stationery Office, 1983.
99. Ontario Royal Commission. Report on matters of health and safety arising from the use of asbestos in Ontario. Toronto: Ontario Ministry of the Attorney General, 1984.
100. Doll R, Peto J. Asbestos: effects on health of exposure to asbestos. London: Her Majesty's Stationery Office, 1985.
101. Corn M. Issues related to the potential health hazard of asbestos-containing materials in buildings. Presented at the Symposium on Health Aspects of Exposure to Asbestos in Buildings, Harvard University, Energy and Environmental Policy Center, Cambridge, Mass., 1989.
102. Massey DG, Foumier-Massey G. Asbestos removal from buildings: a review. Hawaii Med J 1987; 46: 153–7.
103. Sawyer RN, Rohl AN, Langer AM. Airborne fiber control in buildings during asbestos material removal by amended water methodology. Environ Res 1985; 36: 46–55.